Product
Boryung Hepatitis A Vaccine
1 clinical trial
2 indications
Indication
Hepatitis AIndication
Hep AClinical trial
A Randomized, Double-blind, Multicenter, Multinational, Active-controlled, Parallel-designed Phase 3 Clinical Trial to Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24months to 15yrsStatus: Not yet recruiting, Estimated PCD: 2024-07-01